Effectiveness of traditional non-carbapenem β-lactams vs. novel β-lactams for the treatment of carbapenem-resistant Pseudomonas aeruginosa: a retrospective cohort study

Abstract Background The World Health Organization (WHO) has identified carbapenem-resistant Pseudomonas aeruginosa (CRPA) as one of the three critical priority pathogens. There is scarce literature evaluating the treatment outcomes in patients with CRPA infections treated with traditional non-carbap...

Descripció completa

Dades bibliogràfiques

Autors principals:	Namareq F. Aldardeer, Hatun M. Labban, Raghad T. Alhuthil, Seham H. Aljahdali, Moataz H. Alharbi, Riham A. Alharbi, Mohammed I. Al Musawa, Abdulrahman A. Almalki, Thamer A. Almangour
Format:	Artigo
Idioma:	Inglês
Publicat:	BMC 2024-12-01
Col·lecció:	BMC Infectious Diseases
Matèries:	Carbapenem Resistance Pseudomonas aeruginosa Cephalosporins Piperacillin/Tazobactam
Accés en línia:	https://doi.org/10.1186/s12879-024-10365-5
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!